A REVOLUTIONARY fat-busting drug is about to be available on the NHS.
Experts claim the treatment represents the “holy grail” in the fight against obesity.
1
Tubby adults given the weekly jab in trials shed nearly 2½ stone in just 15 months.
That is six times as much weight lost as those who were told to just exercise and diet.
A third on the drug lost more than a fifth of their body weight, similar to results expected from stomach-stapling surgery.
The National Institute for Health and Care Excellence will today recommend semaglutide is made available on the NHS to help morbidly obese patients, with 1.3million in England eligible.
Draft guidance says patients must have at least one obesity-related condition to qualify.
The drug, from Novo Nordisk UK, works by hijacking the brain’s appetite-regulating system, reducing hunger.
Delighted Tam Fry, of the National Obesity Forum, said: “This could be the treatment that finally starts to reverse the obesity epidemic.”
Recommendations could be finalised by summer — with the £73-a-month jab easing pressure on the NHS.